According to the research report titled ‘Pet Diabetes Care Devices Market Size By Device Type (Glucose Monitoring Devices, Insulin Delivery Devices {Insulin Delivery Pen, Insulin Syringes }) By Animal (Cats, Dogs, Horses), By End-use (Veterinary Clinics, Home Care Settings, Veterinary Hospitals), Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2019 - 2025’, available with Market Study Report, global pet diabetes care devices market is projected to attain a valuation of USD 2.8 billion by the end of the forecast period 2019-2025.
 

Increasing cases of pet diabetes, rising prevalence of obesity in pets, and escalating animal healthcare expenditure are the major growth propellers of global pet diabetes care devices market. Besides, growing adoption of pets in developed as well as developing economies will continue to support the industry development.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/2419632/
 

Technological advancements in insulin delivery devices is anticipated to augment the overall remuneration scope of the industry. For instance, Merck designed the first and only veterinary insulin pen for both diabetic cats and dogs, called the Caninsulin VetPen.
 

Despite the positive industry outlook, side effects associated with diabetes medications continue to prove a challenge for businesses in this domain, cites the study.
 

In terms of device, insulin delivery pen segment is anticipated to record 8.8% CAGR over the forecast duration, largely creditable to wide product adoption across veterinary hospitals, clinics, and homecare settings.
 

Based on animal type, global pet diabetes care devices industry value from cats segment was USD 652.4 million in 2018 and is touted to increase considerably during the assessment period. Cases of diabetes in cats are lower than dogs, however, they generally suffer from type 2 diabetes.
 

Considering the end-use spectrum, veterinary hospitals segment accounted for 43% revenue share in 2018 and is predicted to showcase strong growth trends in the upcoming years. Increasing number of veterinary hospitals in developed and developing countries along with rising inclination of pet owners towards these establishments due to availability of latest and advanced technologies are supporting the segmental expansion.
 

From a geographical perspective, UK pet diabetes care devices market size is set to multiply at 8.5% CAGR throughout 2019-2025. This can be ascribed to rising prevalence of diabetes in animals, developing awareness regarding various treatments for pets, and favorable initiatives undertaken by industry players in the country.
 

Top contenders impacting the industry trends are Zoetis Inc., Taidoc Technology Corp., UltiMed Inc., Merck & Co. Inc., Henry Schein Animal Health (Vets First Choice), Fitbark Inc., Becton, Dickinson and Company, Boehringer Ingelheim Vetmedica Inc., Apotex Inc., and Allison Medical Inc.